Download this free whitepaper to learn more.
Scaling a promising biologic from bench to market is a strategic necessity. Biologic developers can turn scalability into a competitive advantage by making smarter early decisions and investing in robust infrastructure.
Access this valuable resource today to explore:
- The key reasons many biologics falter, and what can be done to avoid delayed clinical timelines
- Why decisions around expression systems and scale-down models can make or break scale-up efforts
- How to better align development and manufacturing systems to avoid engineering pitfalls
- Tips for designing facilities that can effectively adapt to shifting demand
- And more
Scalability is a decisive factor in regulatory success and commercial viability. With this report, discover how successful biologic developers are designing for it from the start.
Offered Free by: Avid Bioservices
See All Resources from: Avid Bioservices
